The Valley Desk

NCT01132820 · Interventional trial

Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer

Overall registry status Completed

Phase 2

Conditions Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Recurrent Uterine Corpus Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov